Blood treating material

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

167/199

A61K 31/715 (2006.01) A61K 35/74 (2006.01)

Patent

CA 1204667

BLOOD TREATING AGENT ABSTRACT OF THE DISCLOSURE The present invention provides (1) a blood-treating material containing a lipopolysaccharide derived from cell walls of Gram-negative bacteria and immobilized by an insoluble carrier containing an amino group and/or a carboxyl group, and (2) a process for producing the blood-treating material in which a condensing agent is reacted with a mixture of the lipopolysacchar- ide and the insoluble carrier. Lipopolysaccharides have been known to exhibit antitumor effects against malignant tumors. However, they have not been used safely, since their fatal doses are very close to the minimum effective doses in the treatment of such tumors. The present invention makes it possible to reduce the lethal toxicity of the abovementioned lipopolysacchar- ides and provide a therapy for cancer, because the unique blood- treating material disclosed herein not only has antitumor effects similar to those of the lipopolysaccharides derived from the cell walls of Gram-negative bacteria but no fatal effects are observed at antitumor effective dosage levels.

438186

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Blood treating material does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Blood treating material, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Blood treating material will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1220942

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.